[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-107-2-medical-surgical-022":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":23},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":22},"nurse-107-2-內外科護理學-022","nurse-107-2-medical-surgical-022",107,2,22,"有關青光眼藥物作用的敘述，下列何者正確？",{"A":14,"B":15,"C":16,"D":17},"縮瞳劑可抑制房水液排出","β腎上腺素阻斷劑可抑制房水液生成","乙醯膽鹼酶抑制劑可抑制房水液生成","前列腺素致效劑可抑制房水液生成","B",null,[],"本題考點是青光眼藥物如何降低眼壓——不外乎『減少房水生成』或『促進房水排出』兩機轉。依藥理學,β腎上腺素阻斷劑(如 timolol)作用於睫狀體上皮的β受體,抑制房水液生成而降眼壓,故 B 正確。(A)縮瞳劑(如 pilocarpine)是收縮瞳孔、拉開小樑網『促進』房水排出,非抑制排出;(C)乙醯膽鹼酶抑制劑屬副交感致效類,亦為縮瞳促排出而非抑制生成;(D)前列腺素致效劑(如 latanoprost)是增加葡萄膜鞏膜途徑的房水『排出』,非抑制生成。",1,[24,28,31,35,39,43],{"webId":25,"stem":26,"number":22,"year":27,"session":22},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":29,"stem":30,"number":10,"year":27,"session":22},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":32,"stem":33,"number":34,"year":27,"session":22},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":27,"session":22},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":27,"session":22},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":27,"session":22},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840750882]